Fig 2 shows the number of TB cases among the different TNF inhibitors agents in relation to the total number of cases, with 0.7% of cases occurring with ADA, 1.5% with CZP, 0.2% with ETN, 0.3% with GOL, and 0.4% with IFX. The gene discussed is ADA; the disease is tuberculosis.